Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04585594 · ClinicalTrials.gov registry record · NA
Mi Propio Camino Intervention RCT for Blood Pressure Medication Adherence
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 511
- Enrollment target
NCT04585594: Completed NA study, sponsored by University of California, Irvine.
NCT04585594 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 511 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04585594, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 511 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of two educational interventions on adherence to blood pressure medications among adults with uncontrolled hypertension.
Primary Outcome
Medication adherence is assessed at 6-month follow-up with Medication Event Monitoring System (MEMS) pill bottle cap monitors (MWV/WestRock), an objective, gold-standard measure for pill-taking behavior. MEMS caps can be affixed to a medicine bottle to record each time the bottle is opened, indicating when the patient took the medication. Daily adherence is defined as the proportion of days that the prescribed number of doses was taken by the patient during a 30-day period.
Interventions
- BEHAVIORAL Mi Propio Camino (MPC)
- BEHAVIORAL Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2020-09-16 |
| Est. Completion | 2024-09-10 |
| Phase | NA |
What the finished NCT04585594 record still lists
NCT04585594 is an interventional study that assigns participants to a tested intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Mi Propio Camino (MPC) is the first listed.
NCT04585594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04585594 about?
NCT04585594 is a clinical study titled "Mi Propio Camino Intervention RCT for Blood Pressure Medication Adherence". The purpose of this study is to compare the effect of two educational interventions on adherence to blood pressure medications among adults with uncontrolled hypertension.
What is the current status of trial NCT04585594?
This trial is currently completed. It is a NA study. The enrollment target is 511 participants. The study started on 2020-09-16. Estimated completion is 2024-09-10.
What interventions are being tested in trial NCT04585594?
The interventions under investigation include: Mi Propio Camino (MPC) (BEHAVIORAL), Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04585594?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04585594's enrollment target sits among peer trials
511 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI